Clinical trials recruiting for ANCA Associated Vasculitis (AAV)

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases
  NCT06980597 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• AYLo - AutoimmunitY and Loss of y
  NCT06696027 · Phase: Not specified · Ages: 50 Years and older · Sex: Male · 4 locations
• Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases
  NCT06614270 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
  NCT06941129 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
  NCT07315087 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
  NCT07150000 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
  NCT07089121 · Phase: Phase 1, Phase 2 · Ages: 12 Years and older · Sex: All (male and female) · 3 locations
• FT839 in Autoimmune Diseases
  NCT07800871 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• MTS109 in Patients With Refractory Autoimmune Diseases
  NCT07526350 · Phase: Early Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Rare AutoImmune SElf-management Programme Development
  NCT06642870 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases
  NCT06828042 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for ANCA Associated Vasculitis (AAV) often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for ANCA Associated Vasculitis (AAV) trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.